ÂÜÀòÂÒÂ×

Karen Brantl is a seasoned chemist with extensive experience in research and development, process engineering, and product commercialization across multiple industries. Currently serving as a Senior Principal Chemist at Cardinal Health since September 2018, Brantl previously held significant roles at The Dow Chemical Company, where contributions included the successful commercialization of silane adhesion promoters and development of process control strategies for dielectric polymer prototypes. Other positions include Senior Chemist at Cyalume Technologies, R&D roles at Henkel Loctite Corporation, and experience in process development at Hybridon Specialty Products and Shipley Company. Karen Brantl holds a Master's degree in Chemistry from the University of Saint Joseph and a B.S. in Chemistry from Western New England University.